The Supreme Court of India for Clinical Trials

Embed Size (px)

Citation preview

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    1/22

    The Supreme Court of

    India: Allow the Reviewand Approval Process for

    Clinical Trial Applications

    to Resume1.

    1.

    2. Petition by

    People for the Advancement of Clinical

    Research - India

    The recent decisions made in the Democratic

    Republic of India leadin! to the suspension

    of the revie" and approval process for any

    ne" domestic and !lobal clinical trial

    applications is a catastrophic mista#e. The

    decision directly and ne!atively impacts the

    lives of millions of Indian$s across the

    country under the false premise that the

    actions ta#en "ill protect those individuals.

    http://www.change.org/organizations/people_for_the_advancement_of_clinical_research_-_indiahttp://www.change.org/organizations/people_for_the_advancement_of_clinical_research_-_indiahttp://www.change.org/organizations/people_for_the_advancement_of_clinical_research_-_indiahttp://www.change.org/organizations/people_for_the_advancement_of_clinical_research_-_india
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    2/22

    %o!ical fact-based and statistically supported

    thin#in! and decision ma#in! has been

    sidelined in favor of embellishment made-for-media headlines sound bites and ra"

    unchec#ed passion. &hen combined "ith

    court decisions made durin! the past 1'

    months the result has been a nearly t"o

    year shut do"n of "hat "as one of the

    fastest !ro"in! and most promisin!

    enterprises India has seen since the da"n of

    the ne" millennium. (urthermore data from

    (rost and )ullivan *oston Consultin! +roup

    Price &aterhouse Coopers ,rnst and oun!

    and PRT forecasted that the future couldonly have been bri!hter. Most importantly,

    the vital flow of innovative new and

    potentially life improving treatments

    has come to a complete stop.

    Therefore the People for the Advancement of Clinical

    Research / India 0PACRI has launched this petition tour!e the )upreme Court of India to allo" the relevant

    !overnment bodies to a!ain be!in revie"in! and

    approvin! clinical trials. Throu!h this petition "e "ould

    also li#e to brin! to the front the facts concernin!

    clinical research that are bein! smud!ed in this very

    public media trial. &e reco!nie that the process is notperfect and that chan!es must be committed to

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    3/22

    measured and made in order to meet Court

    e3pectations / but a complete stop is a shortsi!hted

    and unacceptable solution. PACRI is comprised of

    ordinary individuals from the follo"in! !roups4 ordinary

    healthy citiens5 patients5 !overnment officials5 health

    enterprise professionals5 educators5 patient advocacy

    !roups and more.

    *elo" is a list of relevant facts and findin!s re!ardin!

    the importance of clinical research to the physical andeconomic health of the people of India. Readers of this

    petition "ill find that many of these facts lay in star#

    contrast to the often va!ue data points bein! put

    for"ard by the small- yet-loud !roups "ho have stood

    in the "ay of any pro!ress in an effort to create

    pro!ress void of ris#. The !roups fail to reco!nie that

    their often emotive and misinformed statements are

    only turnin! out to be more detrimental to the cause

    they espouse / protection of the research participant.

    The very nature of clinical research and of any

    innovative enterprise is that pro!ress is often frau!ht

    "ith ris#. ore than la" it is the individuals "ho have

    to ensure that the ris# is balanced "ith the benefit anyprocess "ill provide to people and society. If "e are

    realistic "e must reco!nie that man#ind has never

    advanced "ithout it.

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    4/22

    FACT:6e" treatments cannot be brou!ht to mar#et

    and become available at your local pharmacy "ithout

    first under!oin! a ri!orous testin! process in the lab in

    animals and then in humans in the clinic #no"n as

    Clinical Research or Clinical Trials

    FACT:Clinical research "hen properly conducted has a

    !reat potential to help us understand the prevalence of

    various diseases and help us to more effectivelyprevent dia!nose treat and rehabilitate the affected

    population

    FACT:Clinical research has been occurrin! in India for

    decades and the conduct of !lobal clinical trials has

    been occurrin! since 2778

    FACT:There is no such thin! as a clinical trial "ithout

    ris# for the volunteers "ho participate. The very nature

    of a clinical trial is that it is a test to determine "hether

    an investi!ational product can be proven to be a safe

    and effective treatment.

    FACT:The very individuals "ho "ant an e3cessive

    amount of safe !uards imposed have very much

    benefitted from the clinical research process and the

    efforts of volunteers anytime they ta#e a medicine or

    receive treatment from their physician.

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    5/22

    FACT:There is no statistical evidence to support that

    Indian citiens are bein! used as the "orld$s !uineapi!s as is often proposed by the press and uninformed

    advocacy or!aniations. In fact India$s sta#e in the

    conduct of !lobal clinical trials is still very small4 The

    number of clinical trials DC+I approved in India from

    2717-2712 is 1798 "hile !lobally durin! the same

    period :;;28 trials "ere re!istered officially in the 8

    ne" dru!s bet"een 2778 and 2712 is very misleadin! /

    and purposely so / it sells ne"spaper and attracts

    "ebsite visitors. The fact is out of the estimated

    :81777 people "ho participated in clinical trials

    bet"een 2778 and 2712 '? died of trial related causes.

    All other cases of death reported represent individuals

    "ho died of somethin! else "hile participatin! in the

    trial. If those people "ere in@ured or became ill durin!

    the trial / for e3ample a person in a cancer trial falls in

    an accident at home and dies / they are recorded as a

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    6/22

    )erious Adverse ,vent 0)A, / and officially trac#ed and

    reported as part of the data pac#a!e associated "ith a

    ne" dru! application. Therefore 2'9' of the people

    reported in the ne"s to have died durin! a clinical trial

    / died from somethin! that "as determined 6T to be

    caused by the study dru! or trial related procedures.

    India has 1.2* people more than 18= of the "orld$s

    population "hile burdened "ith B22= of cases of

    disease. )o statistics prove that durin! a > year span

    '? people out of 1.2* died from their participation inresearch - research meant to advance treatments

    desi!ned to improve or save lives. &hile A6 loss of life

    is re!rettable and steps should be ta#en to prevent

    such loss there is by no means a !reater ris# of safety

    issues occurrin! in India than there is any other part of

    "orld "here the human race is "or#in! to advancescience and save lives. The deaths in clinical trials are

    not uniue to India. The trials in "hich India

    participated had )A,$s and deaths reported from other

    parts of the "orld.

    FACT:In all of 271; ? !lobal clinical trials "ereapproved for conduct in India. ,ssentially there has

    been no advancement of treatments to"ard approval in

    India for nearly a year due to "idespread overreaction

    and fear. ave people been saved or are "e actually

    losin! thousands of lives as a result of this stoppa!eE

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    7/22

    FACT:India$s +ood Clinical Practice standards / "hich

    outline the processes for the conduct of clinical trials

    are more strin!ent than those follo"ed by the

    international community includin! leadin! clinical

    research countries in the 6orth America &estern

    ,urope Fapan Australia and else"here titled / called

    the International Counsel on armoniation / +ood

    Clinical Practice or IC-+CP.

    FACT:Recent le!islation reuires compensation paid to

    clinical trial volunteers "ho do not receive the intended

    therapeutic effect of the investi!ational dru! or "ho

    receive a placebo 0su!ar pill instead of the

    investi!ational dru!. These t"o reuirements are

    e3otic cannot be found in any other part of the "orld

    "here clinical research e3ists and stri#e ri!ht at the

    heart of the very point of conductin! clinical trials. (irst

    clinical trials are tests of investi!ational medicines so

    the very point of the trial is to see if the treatment has

    the intended effect. )econd to determine "hether the

    treatment is actually "or#in! or if it$s simple the

    perception of the patient a placebo is often used. Theuse of a placebo is a proven mechanism to help ensure

    the validity of the treatment !roup results. Golunteers

    are e3plained these thin!s as part of the informed

    consent process before they even a!ree to participate

    in the study.

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    8/22

    FACT:The )upreme Court is mandatin! the use of

    audio and visual recordin!s of the consent process that

    each clinical trial volunteer must !o throu!h "hen

    decidin! to participate in the trial. This is another

    unprecedented step not found in normal +ood Clinical

    Practice any"here in the "orld "hether established or

    emer!in! mar#et. The time costs and lo!istics of

    implementin! such a measure "ill further slo" the

    clinical research process and create unnecessary

    delays in the advancement of potential ne" treatmentsto the patient population of India. The recommended

    process also does not ta#e into account the t"o ma@or

    !round realities of medical care in India.

    FACT:The patient-doctor relationship in India is very

    stron!ly based on Hfaith. This A-G process "ill

    introduce an element of distrust and discomfort in that

    relationship. Instead of encoura!in! real discussion on

    health and treatment bet"een the doctor and the

    patient it "ill only disen!a!e the t"o parties.

    FACT:A ma@or proportion of the Indian population

    culturally still protects the female !ender in a Jpurdah$

    system. o" "ill "e deal "ith this cultural issue in the

    li!ht of the ease of electronic transmission of data in

    this technolo!ical a!e. &ho "ill protect their privacyE

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    9/22

    FACT:The revie" process that ne" clinical trial

    applications !o throu!h in India is as ri!orous if not

    more ri!orous than most other countries across the

    "orld even those that have been conductin! trials for

    many decades. The past 8 years have seen the

    implementation of a number of ne" re!ulations and

    strict reuirements aimed at ti!htenin! the revie"

    process after some earlier incidents. The resultin! t"o

    step process "hich has been in place for nearly t"o

    years no" ensures that all ne" trial applications notonly under!o the scrutiny of the office of the Dru!s

    Controller +eneral India - but due to le!islative chan!es

    in 2717 - also no" under!o an in-depth evaluation by a

    panel of 17 ob@ective physicians "ho have e3tensive

    e3pertise in the therapeutic areaKdisease bein!

    tar!eted by the clinical trial. nly after passin!successfully throu!h these t"o layers and then bein!

    approved by independent ethics committees located at

    each research center can the trial actually proceed.

    Other Truths about Clinical esearch

    - Clinical trials in India are re!ulated by a set of rules

    that are in conformity "ith / and in some cases surpass

    - !lobal standards

    - The implementation of present set of rules must be

    closely monitored before movin! the !oal post

    - Clinical research "hen properly conducted has a !reat

    potential to help us understand the prevalence of

    various diseases and help us to more effectively

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    10/22

    prevent dia!nose treat and rehabilitate the affected

    population

    - Clinical research has provided medical access tothousands of patients since the policy chan!e in 2778

    - )ince 2778 clinical research has !enerated

    employment to thousands of professionals and has the

    capacity to !enerate employment to a fe" hundred

    thousands of such professionals

    - Clinical research has contributed si!nificantly to the

    !ro"th of laboratories ima!in! lo!istical support and

    other services

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    11/22

    Supporters

    Reasonsfor signing ost Popular

    %atest

    ahesh De!a I6DIA

    o about 2; hours a!o

    o %i#ed 1;

    It is really the slu!!ishness that 6+ and )upreme

    Court are only focusin! on problem.L *annin! Clinical

    Trials in India L is not a solution. )C 6+ and edia

    don$t have #no"led!e about clinical trials. n the other

    hand the deaths due to tobacco products is still the

    ma@or cause in India has not been banned but clinical

    trials "hich causes #no"n deaths is tar!eted to be

    banned. 87= of !lobal clinical trials are conductin! in

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    12/22

    As a cancer sur!eron and clinical researcher I feel that

    the process of scientific pro!ress and biomedical

    research is critical to improve the health of our

    population. All of us "ho practice medicine #no" that it

    is an ine3act science "ith a lar!e number of

    unans"ered uestions and un#no"n facts. Clinical and

    translational research are vital for these !aps in

    #no"led!e to be filled. The fact that "e live lon!er

    today than "e did as recently as 27 years bac# is

    primarily because of the pro!ress made in clinicalresearch - both by industry and academic researchers.

    As it is India has la!!ed !rossly behind developed

    countries in biomedical research5 at a time "hen Indian

    researchers are !ettin! their act to!ether and

    proposin! hi!h uality research embedded stron!ly

    "ith the principles of bioethics it seems cruel to putunfair obstacles in their path. &hile re!ulation is

    important and "elcome they also need to be rational

    and lo!ical. &hat is needed no" is effective

    implementation of e3istin! rules and not #nee-@er#

    reactions and the introduction of ne" restrictive and

    unethical la"s. There is an ur!ent need to establish a

    fair re!ulatory environment "hich facilitates and

    promotes the conduct of hi!h uality biomedical

    research in the country.

    PRITA AMRA I6DIA

    o 1 day a!o

    http://www.change.org/users/68179718http://www.change.org/users/68179718
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    13/22

    o %i#ed :

    Clinical Trial is the only "ay to brin! novel molecules oralternate treatment options in our healthcare system.

    6obody canNt deny itNs important. &e are la!!in!

    behind dude to the present re!ulatory environment in

    the country. ,very coin has t"o side. &e canNt i!nore

    the importance @ust for fe" separate incidence.

    Chan!es are al"ays "elcome since clinical trial is

    directly related to our health but it is not the proper

    "ay our @udiciary system is ma#in! the chan!es. &e

    have already "asted appro3imately 2 years no" it is

    the time to materialied everythin! at earliest.

    Tapan#umar )hah )I6+APR, )I6+APR,

    o about 21 hours a!o

    o %i#ed ;

    &ho are !uinea pi!sE The ones "ho ta#e dru!s that

    have never been tested in India before R those "ho

    participate in clinical trials and are treated "ith respect

    and e3tremely "ell ta#en care ofE The patients "ho

    participate in clinical trials are 6T treated li#e !uinea

    pi!s. They are treated as !reat human bein!s "ho

    support advancement of medical science for the

    !reater !ood of the society for the !ood of millions of

    patients "ho suffer from the diseases that they do.

    http://www.change.org/users/68285646http://www.change.org/users/68285646
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    14/22

    Clinical trials are not an income for the pharmaceutical

    industry. They are rather an e3penditure and a heavy

    one. They spend crores of rupees to ensure that the

    trials are conducted ethically and overseen by "ell

    ualified monitors "ho personally !o to the trial sites

    and verify data to confirm that the ri!hts safety and

    "ell bein! of patients are maintained and that the data

    !enerated are cridible for e3trapolation to the lar!er

    population of the country and the "orld. Clinical trials

    are not optional5 in fact there is no other option. (orthe pharmaceutical industry doin! clinical trials is the

    only "ay to prove that the dru!s are safe and effective

    and only on the basis of clinical trials are the dru!s

    approved in each country by the health authorities

    after thorou!h evaluation.

    Please do not let anyone mis!uide you. Read

    understand consult e3perts and then ta#e your

    decision. Do not #eep uiet because you may suffer

    from a disease for "hich you donNt have a treatment in

    India only because clinical trials on that dru! "ere not

    performed in India. It is truly a uestion of your life.

    Ramesh"ar +aur I6DIA

    o about 2: hours a!o

    o %i#ed ;

    *ecause I used this type for my treatment

    http://www.change.org/users/68296276http://www.change.org/users/68296276
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    15/22

    *ecause I used this type for my treatment

    PFA RA)T+I I6DIA

    o about 18 hours a!o

    o %i#ed 2

    Research is an important aspect of further development

    and pro!ress in every arena of life. &e cannot halt

    research because of fe" people "ho are not "ellinformed or "ron!ly informed. Indian research caters to

    a hu!e population "ith different ethnicity. 6ot doin!

    clinical research in India is li#e @eopardiin! the future

    !enerations to healthKdru! haards "hich some people

    are not even able to anticipate. )o I feel clinical

    research must !et a + 6O Also my ei!ht year old sonfeels that clinical research is very important because he

    does not "ant to see sic# people in his country. &a#e

    up peopleO

    Ale3 Peter +A6DI6A+AR I6DIA

    o about 19 hours a!o

    o %i#ed 2

    Clinical Research has a !reat social purpose- to find

    more effective medicine and treatment procedure for

    man#ind . 6o short cut to avoid the clinical research

    .6o clinical research means ne" medicine. That is

    http://www.change.org/users/68338616http://www.change.org/users/68338616http://www.change.org/users/68314134http://www.change.org/users/68338616http://www.change.org/users/68314134
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    16/22

    a!ainst the ri!ht to life of the patient. &hen standard of

    care fails the patients "ho have life threatenin!

    diseases desperately searchin! for the research

    medicine as a last resort. In several times. it does

    miracles.

    Clinical research comes first. Clinical practice comes

    second. &ithout clinical research Clinical practice "ill

    be sta!nated soon.

    Clinical research and practice should !o hand in hand.

    Clinical Research re!ulation and monitorin! should be a

    continuous process for a conductive environment .

    Anybody can ima!ine to stop the clinical practice to

    avoid the clinical in@uriesE

    ,very effective medicine and treatment save the life of

    the millions .

    In India thousands of patients life e3pectancy and

    uality of life improved to a !reat e3tent because of the

    clinical research .

    "e are e3pectin! a more balanced and industry

    informed order from supreme court soon.

    Girender )an!"an D,RA*AD I6DIA

    o about 19 hours a!o

    http://www.change.org/users/68336670http://www.change.org/users/68336670
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    17/22

    o %i#ed 2

    I have active clinical trial research doctor and

    practioner. 6ot doin! trials is !reat disadvanta!e to us

    and to our patients and society at lar!e.

    Prem Pais *A6+A%R, I6DIA

    o about 1> hours a!o

    o

    %i#ed 2Clinical trials are essential for discovery of ne"

    treatments for the Indian people

    *havani Geeravalli I6DIA

    o about 1' hours a!o

    o %i#ed 2

    y mother suffers from Par#insonNs Disease to "hich

    cure can be found only if clinical trials are conducted

    non stop. +ovt should not stop clinical trials as this

    could mean loss of lives due to lac# of life savin! dru!s

    comin! into the countryO

    could mean loss of lives due to lac# of life savin!

    dru!s comin! into the countryO

    Tapan#umar )hah )I6+APR, )I6+APR,

    o

    about 2; hours a!o

    http://www.change.org/users/68331252http://www.change.org/users/68321551http://www.change.org/users/68321551http://www.change.org/users/68285646http://www.change.org/users/68331252http://www.change.org/users/68321551http://www.change.org/users/68285646
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    18/22

    o %i#ed 2

    &ho are "e punishin! by stoppin! clinical trials in

    IndiaE The microscopic minority of people "ho may not

    have done clinical trials "ell or the people of India "ho

    need ne"er treatment optionsE

    neha chandan

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    19/22

    only after he is informed and has fully understood

    "ould he consent of his o"n free "ill to participate. e

    can "ithdra" consent at any time "ithout sufferin! any

    adverse conseuence or havin! to !ive any reason. e

    "ill be treated free of cost for any adverse event that

    may happen durin! and due to the clinical trial. &hen

    indicated compensation "ill also be done. Careful

    selection of the ri!ht investi!ator ri!orous trainin! and

    close monitorin! audits and inspections are done.

    nly if re!ulatory and ethics committee approvalhappens can a trial be!in. ver the years patients

    have been made safe for CR. ItNs time to no" save CR

    for patients.

    ohit ehrotra %I)%, I%

    o about 1: hours a!o

    o %i#ed 1

    It is critical for advancement of ne" treatments for

    patients in India "hich has about 18= of the "orlds

    population and over 27= of the disease burden. (or

    India to !ro" in importance it must be place "here

    science and research is encoura!ed and flourishes li#e

    the

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    20/22

    o about 1? hours a!o

    o %i#ed 1

    In the lon! run "e "ill suffer since companies "ould

    refuse to launch ne" products in India. &e are

    behavin! as "e the only super po"er in "orld. "e need

    to retrospect and thin# "hat "e have contribute till

    date to the "orld e3cept the sie of the pupulation

    Ravite@ R I6DIA

    o about 1? hours a!o

    o %i#ed 1

    *ecause I oppose this misconception of L

  • 8/13/2019 The Supreme Court of India for Clinical Trials

    21/22

    implications "e are noticin! in terms of business and

    employment in this sector. The need of an hour is

    effective implementations and re!ular chec#s rather

    haltin! the entire process.

    Dr. Prafulla Patil I6DIA

    o about 1? hours a!o

    o

    %i#ed 1As it is unnecessarily affectin! scientific advancement

    and the pro!ress of the country.

    ruhi rupam I6DIA

    o about 27 hours a!o

    o %i#ed 1

    6e" treatment are not available in mar#et "ithout the

    first under!oin! a lab a preclinical trial and clinical trial

    so clinical research and clinical trial is most important .

    ustafa Pardi"ala I6DIA

    o about 27 hours a!o

    o %i#ed 1

    (or !ro"th of Clinical Trail Industry in India

    http://www.change.org/users/68318615http://www.change.org/users/68318615http://www.change.org/users/68313098http://www.change.org/users/68311605http://www.change.org/users/68318615http://www.change.org/users/68313098http://www.change.org/users/68311605
  • 8/13/2019 The Supreme Court of India for Clinical Trials

    22/22

    Chandana Pal D,RA*AD I6DIA

    o about 21 hours a!o

    o %i#ed 1

    India "ith its hu!e population and vast pool of

    diseased needs an ever emer!in! ran!e of dru!s and

    therapies. This could be possible only "hen the clinical

    research industry "or#s in tandem "ith the societal

    need. &e had started "ith a !reat promise butsomeho" lost the momentum mid "ay throu!h as this

    industry "as sin!ularly ta#en for media inspection and

    sympathy !arnerin!. The hi!hs attained "ere

    beautifully blinded by the lo"s depicted by the media.

    The industry came to a !rindin! halt almost ; years

    bac# and today a country "hich "as sho"in! a !reat

    promise in an upcomin! industry is tryin! to find a

    footin! a!ain. (or the benefit of the society at lar!e and

    the industry "hich caters to health and "ell bein! it is

    hi!h time "e start the process of !ettin! and doin!

    research trials a!ain . The chan!es in the policies and

    the administration can !o on hand in hand "hile the

    clinical trial processes resume.

    http://www.change.org/users/68309253http://www.change.org/users/68309253http://www.change.org/users/68309253